Nippon India Pharma Fund Direct Plan Payout Inc Dist cum Cap Wdrl
Add To Comparepreviously known as Nippon India Pharma Dir DP until
NAV on September 03, 2026
Category
Equity:
Sector - Healthcare
Sector - Healthcare
Investment StyleBox
Large Growth
Total Assets
₹9,279 cr
Turnover Ratio
14.27%
Expense Ratio
1.00%
Exit Load
1.00%
if redeemed within
Returns
- 1M: Positive return: 0.32%
- 1Y: Positive return: 12.02%
- 3M: Positive return: 8.47%
- 3Y: Positive return: 18.95%
- 6M: Positive return: 12.42%
- 5Y: Positive return: 14.04%
Other plans of Nippon India Pharma